Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex Expands in Singapore, Dubai

NEW YORK (GenomeWeb News) – Mass spectrometry technology firm AB Sciex said this week that it has recently expanded its manufacturing and operations in Asia and the Middle East with the opening of new facilities in Singapore and Dubai.

The Singapore facility is an R&D and manufacturing center, and is an extension of the firm's current facilities in the Marsiling district where it produces the AB Sciex 6500 series and TripleTOF series instruments. The company said today that the AB Sciex R&D Centre was created to bring R&D, product development, and manufacturing activities together, and it was expanded to make it possible to manufacture more of its products there.

AB Sciex also said it has transferred the manufacturing of Eksigent chromatography products from the US to Singapore.

On Tuesday, the firm said it also has opened a new regional office and technical support center in Dubai to support its customers in the Middle East region. The new Dubai center provides customer support before and after sale of products, and it provides training and application support through a stream of continuing education courses, AB Sciex said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.